Overview

EC905 Pharmacokinetic Profile Study

Status:
Completed

Trial end date:
2009-07-01

Target enrollment:

Participant gender:

Summary

A study to compare the pharmacokinetics of tamsulosin HCl and solifenacin succinate after co-administration of single entity tablets and of the combination tablet EC905 under steady state conditions at three dose strengths.

Phase:

Phase 1

Details

Lead Sponsor:

Astellas Pharma Europe B.V.

Treatments:

Solifenacin Succinate
Tamsulosin